GOGFX
Price
$46.19
Change
+$0.59 (+1.29%)
Updated
Jun 9 closing price
Net Assets
4.57B
VISVX
Price
$56.96
Change
+$0.70 (+1.24%)
Updated
Jun 9 closing price
Net Assets
65.47B
Interact to see
Advertisement

GOGFX vs VISVX

Header iconGOGFX vs VISVX Comparison
Open Charts GOGFX vs VISVXBanner chart's image
GOGFX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
GOGFX vs. VISVX commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOGFX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 65.5B vs. GOGFX (4.57B). VISVX pays higher dividends than GOGFX: VISVX (1.65) vs GOGFX (0.46). GOGFX was incepted earlier than VISVX: GOGFX (43 years) vs VISVX (28 years). GOGFX (1.44) is less costly to investors than VISVX (0.19). GOGFX is a more actively managed with annual turnover of: 50.00 vs. VISVX (25.00). GOGFX (0) and VISVX (0) have matching initial minimum investment requirements. VISVX annual gain was more profitable for investors over the last year : 22.41 vs. GOGFX (17.83). VISVX return over 5 years is better than : 34.79 vs. GOGFX (-11.30).
GOGFXVISVXGOGFX / VISVX
Total Expense Ratio1.440.19758%
Annual Report Gross Expense Ratio1.440.19758%
Fund Existence43 years28 years-
Gain YTD14.42910.887133%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets4.57B65.5B7%
Annual Yield % from dividends0.461.6528%
Returns for 1 year17.8322.4180%
Returns for 3 years8.4647.1218%
Returns for 5 years-11.3034.79-32%
Returns for 10 years29.55130.8723%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAVI7.960.18
+2.31%
Navient Corp
CW733.5712.24
+1.70%
Curtiss-Wright Corp
ITRI82.360.56
+0.68%
Itron
EMPG17.36N/A
N/A
Empro Group Inc
BOLT4.62-0.10
-2.12%
Bolt Biotherapeutics Inc